Showing 1 - 17 results of 17 for search 'Ho Ji', query time: 0.05s
Refine Results
-
1
-
2
Flight Control Law for Stabilizing Transient Response of the Aircraft during Gun Firing by Chang-ho Ji, Chongsup Kim, Byoung Soo Kim
Published 2023-04-01
Article -
3
-
4
-
5
-
6
-
7
Modified FOLFIRINOX as a Second-Line Treatment for Patients with Gemcitabine-Failed Advanced Biliary Tract Cancer: A Prospective Multicenter Phase II Study by Yong-Pyo Lee, Sung Yong Oh, Kwang Min Kim, Se-Il Go, Jung Hoon Kim, Seok Jae Huh, Jung Hun Kang, Jun Ho Ji
Published 2022-04-01
Article -
8
-
9
-
10
β-Sitosterol Attenuates Dexamethasone-Induced Muscle Atrophy via Regulating FoxO1-Dependent Signaling in C2C12 Cell and Mice Model by Young-Sool Hah, Won Keong Lee, Sangyeob Lee, Eun Ji Kim, Jung Hyeon Lee, Seung-Jun Lee, Yeong Ho Ji, Sang Gon Kim, Hyeong-Hwan Lee, Seo Yeon Hong, Jun-Il Yoo
Published 2022-07-01
Article -
11
Comparison of survival outcomes between de novo and recurrent stage IV gastric cancers: A retrospective cohort study by Jun Ho Ji, Kwang Min Kim, Byung Soo Kwan, Sung Kim, Yong Seok Kim, Seong Hee Choi, Mi Hyeon Jin, Boo Young Ha, Jinah Kim, Jeff Liang, Naomy Kim, Dan bi Lee, Ju Dong Yang
Published 2023-06-01
Article -
12
-
13
Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis by Jaekyung Cheon, Choong-kun Lee, Yun Beom Sang, Hye Jin Choi, Min Hwan Kim, Jun Ho Ji, Kwang Hyun Ko, Chang-Il Kwon, Dae Jung Kim, Sung Hoon Choi, Chan Kim, Beodeul Kang, Hong Jae Chon
Published 2021-08-01
Article -
14
Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors by Hye Ryeon Kim, Jung Hun Kang, Sung Hyun Kim, Seung Tae Kim, Ilhwan Kim, Young Joo Min, Seong Hoon Shin, Sung Yong Oh, Gyeong-Won Lee, Ji Hyun Lee, Jun Ho Ji, Seok Jae Huh, Suee Lee
Published 2022-07-01
Article -
15
Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer. by Jun Ho Ji, Young Lyun Oh, Mineui Hong, Jae Won Yun, Hyun-Woo Lee, DeokGeun Kim, Yongick Ji, Duk-Hwan Kim, Woong-Yang Park, Hyun-Tae Shin, Kyoung-Mee Kim, Myung-Ju Ahn, Keunchil Park, Jong-Mu Sun
Published 2015-08-01
Article -
16
Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study by Sung Yong Oh, Won Seog Kim, Jin Seok Kim, Seok Jin Kim, Dok Hyun Yoon, Deok-Hwan Yang, Won Sik Lee, Hyo Jung Kim, Ho-Young Yhim, Seong Hyun Jeong, Jong Ho Won, Suee Lee, Jee Hyun Kong, Sung-Nam Lim, Jun Ho Ji, Kyung A. Kwon, Gyeong-Won Lee, Jae Hoon Lee, Ho Sup Lee, Ho-Jin Shin, Cheolwon Suh
Published 2019-10-01
Article -
17
Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report by Yuanbin Chen, MD, PhD, Luis Paz-Ares, MD, PhD, Niels Reinmuth, MD, PhD, Marina Chiara Garassino, MD, Galina Statsenko, MD, Maximilian J. Hochmair, MD, Mustafa Özgüroğlu, MD, PhD, Francesco Verderame, MD, Libor Havel, MD, György Losonczy, MD, PhD, Nikolay V. Conev, MD, PhD, Katsuyuki Hotta, MD, PhD, MPH, Jun Ho Ji, MD, PhD, Stuart Spencer, MSc, Tapashi Dalvi, PhD, MPH, Haiyi Jiang, MD, Jonathan W. Goldman, MD
Published 2022-06-01
Article